FIELD: pharmaceuticals; medicine.
SUBSTANCE: group of inventions is directed to the treatment of cancer of the nervous system. The use of a compound of formula (IIa) or a pharmaceutically acceptable salt thereof for the treatment or prevention of cancer of the central nervous system in a subject is disclosed, where X is -(CH2)n-X', where n is 0 to 6, and X' is -CHO, -OH, -OR or -OC(=O)R, where R is methyl; R1 is -OH or -O(P(=O)(OH)O)nH where n is 1 to 3; and R2 is -OH. In addition, a kit for the treatment or prevention of cancer of the central nervous system is disclosed, containing a compound of formula (IIa) or a pharmaceutically acceptable salt thereof and another anticancer agent, which is temozolomide or 5-fluorouracil, a pharmaceutical composition for the treatment or prevention of cancer of the central nervous system, and also the use of the above compound for the preparation of a medicament for the treatment or prevention of cancer of the central nervous system in a subject.
EFFECT: group of inventions provides effective treatment of cancer of the central nervous system.
30 cl, 15 dwg, 7 tbl, 17 ex
Formula (IIa)
Title | Year | Author | Number |
---|---|---|---|
METHODS OF TREATING CANCER DISEASES AND TUMORS USING PDE1 INHIBITORS | 2019 |
|
RU2811918C2 |
CEREBRAL CANCER TREATMENT WITH ONCOLYTIC ADENOVIRUS | 2014 |
|
RU2689553C2 |
USE OF THE ANTI-O-ACETYLATED GANGLIOSIDE GD2 ANTIBODY FOR IMPROVING THE THERAPEUTIC POTENTIAL OF DRUGS | 2017 |
|
RU2771173C2 |
PROCASPASE COMBINED THERAPY WITH GLYBLASTOMA | 2013 |
|
RU2636234C2 |
TREATMENT OF CANCER BY PARVOVIRUS IN COMBINATION WITH BEVACIZUMAB | 2016 |
|
RU2679442C1 |
USE OF INHIBITORS OF IMMUNE CONTROL POINTS IN NEW GROWTHS OF CENTRAL NERVOUS SYSTEM | 2015 |
|
RU2726996C1 |
METHOD FOR TREATING A BRAIN TUMOR | 2016 |
|
RU2728796C2 |
CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS (FOR INSTANCE, SERMS OR ALKYLATING AGENTS) | 2009 |
|
RU2543034C2 |
METHOD OF TREATING CANCER ASSOCIATED WITH A RAS MUTATION | 2016 |
|
RU2736045C2 |
PHARMACEUTICAL COMPOSITIONS, COMPOUNDS, METHODS OF SYNTHESIS OF COMPOUNDS | 1995 |
|
RU2168995C2 |
Authors
Dates
2023-06-06—Published
2020-02-03—Filed